March 05, 2026

Prisms, Vision Therapy Reduce AACE

Retrospective cohort shows 79% of patients improved without surgery, with measurable gains in divergence and reduced esodeviation

Conexiant

March 01, 2026

Myopia Beyond 2025

This course is designed to help readers understand the development of the disease of myopia. The article identifies areas in which clinicians can intervene to slow progression using the latest research evidence from the past year.

Contact Lens Spectrum

March 01, 2026

Optimizing Treatment in Low Myopes

Discover how adjusting orthokeratology parameters can optimize myopia control in young children, insights from Dr. Brooke M. Messer.

Contact Lens Spectrum

March 01, 2026

Reclaim Clear Vision

This clinical guide outlines how to counsel and educate parents and children through the ortho-k process to enable long-term success.

Contact Lens Spectrum

January 01, 2026

Myopia Masterclass

Everything you needed to know about myopia—from disease to treatment to practice management.

Eyecare Business

February 16, 2026

Lutein in Children: What Changed?

Six-month trial evaluates choroidal thickness and axial length

Conexiant

November 01, 2025

No-Fee CE: The Latest and Greatest in Soft Lenses

This course highlights cutting-edge innovations in soft contact lenses, including new materials, advanced optics, adverse event updates, and aftercare improvements.

Contact Lens Spectrum

January 01, 2021

Viewpoint

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Optometric Management

December 01, 2020

MYOPIA MATTERS

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Contact Lens Spectrum

November 15, 2024

Eyenovia Halts Eye Drug Trial

Eyenovia's late-stage study for near-sightedness in children with an experimental drug-device combination has been discontinued after failing to slow myopia progression, leading to consideration of strategic alternatives.

Reuters